NMRK's One-Session "Breakout" Died. $14.80 Now Decides the Trap
Deck: NewmarkNMRK-- poked above its 200-day moving average on Friday and lost 3.8% the very next session, returning the stock to the floor where its record earnings got sold. Everyone who bought the reclaim is now trapped — and the whole setup compresses onto one level.
As of 10:47 a.m. ET Tuesday, Sept. 1, Newmark GroupNMRK-- (NMRK) trades near $15.15 after dipping to $14.83 at its lowest, down slightly from Monday's $15.23 close. This is a roughly $2.8 billion commercial real estate services firm, and right now its chart is a collision between a floor that has held since spring and a ceiling that rejected the bulls in a single session.
A reclaim that lasted one session
Newmark closed Friday, Aug. 28, at $15.83 — just above its 200-day moving average, which sits around $15.75 on current data. That matters because Newmark has lived below that line for most of this year. It matters more that the reclaim lasted exactly one trading day: Monday the shares fell about 3.8% to $15.23, and this morning they undercut that to $14.83 before stabilizing.
Read together, Friday and Monday describe a failed breakout — and a failed breakout is a trap for a specific group: the traders who bought the reclaim. They are now about 4% underwater, and they become the supply on the next bounce, the first people lining up to sell Newmark into its next rally attempt.
Why the floor is a floor
The level being retested this morning has real history. The stock closed at $14.79 on May 14 during the spring selling. It flushed lower again after reporting second-quarter results on July 29 — revenue of $888.4 million, up 17% to a record, an eighth straight quarter of double-digit growth — and still sold off hard, around 8%, as investors weighed an unchanged full-year outlook and a cautious tone on capital allocation. Adjusted earnings per share of $0.39 came in roughly in line, but operating margin slipped to 4.5% from 5.6% a year earlier. That is the "good news, sold anyway" DNA this stock has carried all year: the market wants margin quality and deal-flow proof, not just revenue growth.
Now, three pullbacks later, the stock sits at $14.83 — inside the same $14.75–$14.85 zone that caught it in May and again in July. That zone has earned its name. It is not a round number invented from today's quote.
What's missing from today's defense
The early bid at $14.83 deserves a skeptical look. It is arriving on thin tape: block and large prints have skewed to the sell side so far today, while medium-sized orders are doing the dip-buying — participation from smaller accounts, not the institutional sponsorship a durable bottom usually requires. The stock's average true range is about $0.52, roughly 3.4% of a $15 price, so this morning's swing is, by the stock's own standards, a quiet day. When this name moves, it tends to move in 3–4% chunks — the size of Friday's pop and Monday's drop, exactly.
There is also a catalyst overhang the chart cannot draw. CEO Barry Gosin, in the role since 1979, steps down on December 31, and the board had not named his successor at the time of the announcement — a transition discount that can lift quickly if a strong name lands, or keep sentiment sticky while it drags. The August bounce got a boost from Barclays raising its target to $20 on August 17 with an overweight rating, but price targets do not buy stock. Buyers at $15.83 did, and those are the ones trapped now.
The decision map
Everything now runs through the $14.75–$14.85 zone. Below it sits the risk side: a daily close under $14.75 takes out the spring-and-summer floor in one move, and the next marker with real memory is the $13.36 52-week low, roughly 10% lower. Above it, the path is a two-step climb: first a daily close back over the 50-day at $15.39, then a repeat test of the $15.75–$15.83 shelf. A second reclaim there would flip Friday's failure from a broken breakout into a shakeout — turning the trapped chase-buyers back into fuel — and the box from $14.80 to $15.83 projects toward $16.80.
| Scenario | Trigger | Path | Killed by |
|---|---|---|---|
| Continuation up | Daily close above $15.39 (50-day) | Retest $15.75–$15.83, then toward $16.80 | Close below $14.75 |
| Breakdown | Daily close below $14.75 | Toward $13.36 52-week low | Close above $15.39 |
Horizon: days to a couple of weeks, not quarters. This is a swing decision and it decays fast — the failed breakout is already two sessions old, and today's retest only counts if the stock closes back above the 50-day. Buying the intraday dip before that close means betting on a defense that has not yet survived a single daily close.
The verdict
Hold the $14.75–$14.85 floor and Friday's failed breakout stays a bear trap — a double-bottom retest with a straight path back at the 200-day. Close below it, and the buyers who defended support across three pullbacks join the breakout chasers as trapped inventory feeding the next leg down. The setup has until the close to prove which group is wrong.
Everything leaves a footprint. The chart already knows.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet